Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: BDR who wrote (6462)	5/4/1999 11:07:00 PM
From: Linda Kaplan	Respond to of 7041

LOL. Well said. Is it possible that the data they so arduously obtained from Mexico was not presentable? Or do you think they just don't want to spoil the surprise about how great this drug really is? And they'll spring all that data on us after the FDA approves, if it does approve? I don't know why, but I somehow think they'd let us know if they had some favorable data. Just silly of me, I guess. --Linda

To: BDR who wrote (6462)	5/5/1999 9:35:00 AM
From: Bob Trocchi	Read Replies (1) \| Respond to of 7041

dale... >>It is part of Schering's plan to keep Vasomax secret until the last minute. << To borrow a phrase I like from Damien Laker, a fellow SI Poster, Schering uses "Stealth Marketing Techniques" as it relates to Vasomax! Cheers Bob T.